Last reviewed · How we verify
Placebo of Dutasteride Capsule — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Dutasteride Capsule (Placebo of Dutasteride Capsule) — Chong Kun Dang Pharmaceutical. This is a placebo control formulation containing no active pharmaceutical ingredient, used as a comparator in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Dutasteride Capsule TARGET | Placebo of Dutasteride Capsule | Chong Kun Dang Pharmaceutical | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Dutasteride Capsule CI watch — RSS
- Placebo of Dutasteride Capsule CI watch — Atom
- Placebo of Dutasteride Capsule CI watch — JSON
- Placebo of Dutasteride Capsule alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Dutasteride Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-dutasteride-capsule. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab